KKR Real Estate Finance Trust Inc
NYSE:KREF
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.89
13.79
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2024 Analysis
KKR Real Estate Finance Trust Inc
As KKR Real Estate Finance Trust (KREF) navigates an evolving market, the company finds itself in a favorable position with the onset of an interest rate cut cycle. This shift is expected to bolster commercial real estate property values significantly. KREF notes a 40% increase in transaction volumes within their real estate credit pipeline, bringing it to approximately $20 billion weekly. This surge indicates that KREF anticipates substantial lending opportunities ahead, despite reduced market share of traditional lenders, which is expected to drop from their historic average of 40%.
In Q3 2024, KREF faced a GAAP net loss of $13 million, or $0.19 per share. This was largely attributed to an increase in the Current Expected Credit Loss (CECL) allowance of $0.52 per share, driven by two loan downgrades. In contrast, the company demonstrated positive operational outcomes with distributable earnings of $25.9 million, translating to $0.31 per share, comfortably covering its dividend of $0.25 per share. However, the book value per share sagged by 2.6%, landing at $14.84, affected largely by loan rating adjustments.
The company exhibits strong liquidity, maintaining $638 million in available capital, comprised of $109 million in cash and $475 million of undrawn revolver capacity. With a focus on utilizing repayments effectively, KREF reported $290 million in loan repayments in Q3 against $55 million in new fundings. This continued trend has resulted in repayments exceeding fundings for five of the last six quarters, and the outlook remains optimistic for 2025, with anticipated repayments expected to surpass those of 2024.
In addressing credit quality concerns, KREF stated that its 4-rated loans now constitute only 3% of its total portfolio, the lowest level since Q4 2019. The proactive management of watch list loans has been crucial, with no new additions in this quarter, although two loans were downgraded. The company continues to focus on rehabilitating these loans, expecting that improved market conditions will further enhance performance in the multifamily sector amidst varying challenges.
Going forward, KREF plans to ramp up originations actively, leveraging the substantial liquidity and observing positive market signals, especially in multifamily, industrial, and data center investments, including a focus on transitional loans. The management targets to maintain portfolio size while optimizing its real estate owned (REO) assets, predicting an additional $0.12 per share in quarterly distributable earnings from this optimization. 2025 is positioned as an active origination year, aligning with more normalized market conditions.
With the company positioned on the brink of a demand recovery, KREF anticipates substantial activity in the capital markets, pushing forward in its acquisition and refinancing strategies. The management envisions 2025 as a defining year in acquisition velocity, particularly as the balance between buyers and sellers stabilizes, which may also result in favorable cap rates across property types.
Good morning, and welcome to the KKR Real Estate Finance Trust, Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Jack Switala.
Great. Thanks, operator, and welcome to the KKR Real Estate Finance Trust earnings call for the third quarter of 2024. As the operator mentioned, this is Jack Switala. This morning, I'm joined on the call by our CEO, Matt Salem; our President and COO, Patrick Mattson; and our CFO, Kendra Decious.
I'd like to remind everyone that we will refer to certain non-GAAP financial measures on the call, which are reconciled to GAAP figures in our earnings release and in the supplementary presentation, both of which are available on the Investor Relations portion of our website. This call will also contain certain forward-looking statements, which do not guarantee future events or performance. Please refer to our most recently filed 10-Q for cautionary factors related to these statements.
Before I turn the call over to Matt, I'll provide a brief recap of our results. For the third quarter of 2024, we reported GAAP net loss of negative $13 million or negative $0.19 per share, driven by a CECL allowance increase of $0.52 per share, following the additional downgrade of 2 loans. As a result, book value per share decreased 2.6% quarter-over-quarter to $14.84 per share as of September 30, 2024. Distributable earnings this quarter were $25.9 million or $0.31 per share relative to our Q3 $0.25 per share dividend.
With that, I'd now like to turn the call over to Matt.
Thank you, Jack. Good morning, everyone, and thank you for joining our call today.
Before going into third quarter results, I'd like to spend some time on a market update. As we enter an interest rate cut cycle, there's increased confidence in growing consensus that lower interest rates will provide tailwinds for commercial real estate property values. We are seeing improved transaction volumes within our own real estate credit pipeline, which currently averages approximately $20 billion a week, up 40% from the beginning of the year. And we have strong conviction that there is a significant lending opportunity ahead of us.
From a KKR Real Estate equity perspective, 2024 has been our most active year investing since inception with $4.5 billion year-to-date of equity invested in the United States. Within commercial real estate lending, we've seen U.S. banks continue to shift their preference from direct mortgage origination to financing alternative lenders through loan-on-loan facilities. Given the more efficient capital treatment of loan-on-loan facilities, we believe this will continue. Banks will continue to lend, but our expectation is that their market share will decrease from their historical average of 40%. This should create incremental lending opportunities across non-bank lenders and CMBS measured in the hundreds of billions.
Turning to KREF. We've reached a point where we believe we have dealt with the majority of our watch list and have ample liquidity. Therefore, as we receive future repayments, we will look to actively reinvest that capital and ramp up originations. As part of our investment allocation, we will also evaluate share repurchases. As a reminder, KREF has bought back nearly $100 million of stock since inception.
Turning now to KREF's third quarter results. This quarter represents another significant step forward in addressing our watch list in a proactive and transparent way. As we mentioned on our last call, we've been focused on resolving our last 4-rated life science loan, and we are in advanced discussions with our borrower and have accordingly increased our reserves. In addition, we transitioned one of our 4-rated multifamily loans to a 5 rating. As a whole, we still feel very confident about our multifamily exposure. But as we have messaged previously, we will have some noise in that sector over time.
With those adjustments, book value per share this quarter declined to $14.84 per share, down 2.6% compared to the prior quarter. Importantly, our 4-rated loans now represent only 3% of our total portfolio, the lowest since the fourth quarter of 2019. KREF reported distributable earnings prior to realized losses of $0.40, covering our $0.25 dividend. While lower SOFR and our REO portfolio will impact earnings, we expect that DE ex losses will continue to be higher than our dividend as we head into 2025.
In the third quarter, we received $290 million in loan repayments compared to $55 million in fundings with full repayments across 4 loans, including multifamily, single-family rental and an office loan secured by a property located in Oakland, California. In addition to this, post quarter end, we sold a $138 million office loan at par. Repayments have now exceeded fundings in 5 of the last 6 quarters. Additionally, future funding obligations are now reduced to 8% of the funded portfolio. Year-to-date, we have received over $1 billion in repayments compared to our original expectation of $1 billion for the full year.
KREF as an externally managed vehicle benefits from access to resources and relationships from KKR's global platform. We are fully integrated into KKR's broader real estate business, which has assets under management of approximately $75 billion. This integration has been instrumental as we are able to leverage the resources and capabilities of our team of approximately 140 professionals with a reputation as a best-in-class investor and solutions provider.
Within real estate credit, we invest a broad range of capital across the risk-reward spectrum, including bank, insurance and transitional capital. And we've been actively investing this capital throughout the cycle. Additionally, our dedicated K-Star Asset Management platform with over 55 people across loan asset management, special servicing and REO has a portfolio of over $33 billion in loans and is named Special Servicer on an additional $46 billion of CMBS.
Overall, we believe we have been proactive and transparent in managing our portfolio and feel confident in how the company is positioned. We are primarily focused on 2 things as we round out the year and turn the calendar. First, maintain our current portfolio size by reinvesting repayments into this attractive vintage of real estate credit. Second, optimize our REO portfolio. As a reminder, as we repatriate our equity in the REO portfolio, we believe we can generate an additional $0.12 per share in distributable earnings per quarter. With ample liquidity, stronger than expected repayments as well as our reduced leverage ratio, we are excited about the opportunity ahead.
With that, I'll hand the call over to Patrick.
Thanks, Matt. Good morning, everyone. On the liability side, with the assistance of the KKR Capital Markets team, we have built best-in-class diversified financing with financing capacity totaling $8.3 billion, including $3 billion of undrawn capacity. We continue to maintain high levels of liquidity with $638 million of availability at quarter end, including $109 million of cash on hand and $475 million of undrawn revolver capacity. 79% of our financing continues to be fully non-mark-to-market and the remaining balance is mark-to-credit only. KREF has no final facility maturities until 2026 and no corporate debt due until 2027. The composition of KREF's financing structure remains a true differentiator and has helped us navigate a challenged real estate market.
Turning to our office loan exposure. We've had some positive developments. During the quarter, we received a final repayment on a loan secured by an office property located in Oakland, California. In addition, subsequent to quarter end, we sold a $138 million office loan at par, secured by a property located in Dallas, Texas that we originated in December 2021. On a pro forma basis, office now represents approximately 18% of our loan portfolio. Our remaining risk-rated 3 office assets benefit from a weighted average occupancy of 85% and a weighted average lease remaining term of 10.4 years.
Moving to our CECL allowance and our watch list portfolio. Similar to last quarter, there were no new additions to the watch list. However, we downgraded 2 of the previously risk-rated 4 loans, including a life science asset located in the Bay Area and a multifamily asset located in West Hollywood. Related to these downgrades, the CECL reserve increased by $36 million or $0.52 per share. Across our risk-rated 5 loans, the weighted average CECL reserve represents approximately 25% of the outstanding principal balance. The remainder of the loan portfolio remains stable with over 90% of our portfolio risk-rated 3 or better.
Looking more closely at our life science loan. This loan is collateralized by a property located in San Carlos, California that was renovated in 2023 to Class A life science standards. We're in the final stages of a modification with the sponsor, which we expect to conclude in Q4 '24, at which point we expect our reserve to translate to a realized loss. While we generally expect the lower rate environment to improve the outlook for cyclically challenged multifamily assets, our second downgrade this quarter is a multifamily loan secured by a 37-unit Class A luxury rental located in West Hollywood, California. This particular loan has been on the watch list since Q4 '22 and we're exploring several paths to maximize value, including a potential foreclosure and condo sell-out.
Repayments have been progressing slightly better than forecasted, driving further deleveraging. As of Q3, the debt-to-equity ratio is 1.8x and the look-through leverage ratio is 3.8x, an improvement from Q2. While it's always difficult to forecast the precise timing of repayments, and there can be quarter-to-quarter fluctuations, we expect repayment activity to continue to increase with 2025 exceeding 2024 repayment levels. With leverage in our target zone, meaningful progress on the watch list and strong levels of liquidity, additional repayments in excess of future funding needs will be redeployed into new loan originations. We're engaging the market to quote new KREF loans and anticipate 2025 will be an active origination year.
As Matt noted on last quarter's call, we continue to believe that while we are not out of the woods yet, we are on the edge of the woods. And as a management team, we remain excited about our business and momentum. We have never felt better about our team and the market position of the real estate credit platform and believe we have a lot of opportunity ahead of us given the market dynamics.
Thank you again for joining us this morning. And now we're happy to take your questions.
[Operator Instructions] And our first question today comes from Rick Shane with JPMorgan.
Given what you're describing in terms of the operating environment in a little bit more clarity, both in terms of loan values and property values, can you give us a sense of what's happening in terms of price discovery? Are we starting to see expectations between bid and offer narrow? And where is that narrowing occurring with sort of within your range of expectations?
Rick, thank you for the questions and for joining the call. It's Matt. I can take that question. Yes, I think you are seeing transaction volumes pick-up across the industry. And if you look at our own portfolio, we track not only -- or our own pipeline, excuse me, we track not only the weekly activity coming through it, but the percent of that activity that's acquisition-oriented versus refinance-oriented. Last year, we bottomed out around 10% of our pipeline on a weekly basis was in acquisitions. That's up into, call it, 20%-plus today. Historically, that's averaged closer to 50%. So we're still below certainly a normal operating environment, but clearly picking up off kind of off the bottom, which is what you'd expect.
I think there's a lot of transparency in the market today around values, especially in the on favor -- in favored asset classes. And as we mentioned on the call, for instance, from a KKR Real Estate equity perspective, this has been our most active year-to-date acquiring assets. And certainly, there's been competition in those processes. And so whether we're thinking about it from our equity or within our own pipeline and our clients, like we're seeing a lot of transactions predominantly focused in multifamily, industrial, student housing, some of the assets that have the more identifiable long-term positive trends, obviously, versus office. And I think values are settling in kind of around where we would expect. So I don't think we have a very contrarian view to where the market is valuing real estate today.
And the big question in my mind over the last year has not been where are the buyers. I think it's been where are the sellers? And do the sellers -- are they -- can they hold out on an existing financing? And do they have time to wait for values to settle down and cap rates to potentially come in a little bit. And I think you're starting to see that gap narrow as the cost of capital has come down a little bit. I think we've experienced cap rates coming down across property types over the course of the last couple of quarters as the rate complex has cleared up. And so this just feels like it's part of the normal reset within real estate. And our expectation is that 2025 will look like a much more normal year in terms of acquisitions and overall transaction volumes.
Got it. Okay, helpful. And then the other question, and you may have said this and I might have missed it, but can you tell us what the quarterly impact on distributable earnings is from loans on cost recovery?
Rick, it's Kendra. Thanks for the question. So for the 2 new loans that were downgraded to 5, there was a movement of about $0.02 per share of interest income out of Q3. Besides that, there were no other changes in run rate interest income.
And our next question comes from Stephen Laws with Raymond James.
Matt, kind of curious, as you turn the origination pipeline back on, where are you going to be focused? I mean, clearly, banks have pulled back, and so there's a void of construction financing granted it doesn't get a lot of capital off the door and there's unfunded commitments associated with that. It seems like the market is still really competitive for cash flowing multi, especially from CLO players. So can you talk about kind of how you expect the pipeline to build and where your focus is going to be as you redeploy capital?
Thank you for the question, Stephen. Sure, I can take that one. First of all, I don't think it's going to be too different from what we've done in the past. We've always been thematic investors and trying to leverage a lot of the information we have on the equity side of the business where we own real estate. And so I think that continues to lead us down the path of multifamily, industrial, student housing, et cetera.
Certainly, on the newer front, there's probably 2 areas that we're actively looking at. One would be data centers, especially hyperscale construction that are net leased. There's a lot of that opportunity in the market today. As you mentioned, that it's not a perfect product for KREF just given the future funding associated with it, but dollars could get into the ground relatively quickly on that construction project -- on those type of construction projects. So an area we're certainly looking at.
And then the second one I would identify, and I think we mentioned this on the last call, is Europe. And we've built out the team there over the last couple of years and are actively lending in that market. So I think the opportunity for us to really go to where we see relative value from Western Europe all the way to the United States will be interesting. And certainly, that's a market where we've had some success over the course of the last year or 2 investing transitional type of capital. So I'm hoping that market continues to offer those type of opportunities and we could potentially have some investing in that new -- in a new market for us as well.
Right. And to follow-up on your comments in the prepared remarks on note-on-note financing, can you talk a little bit more about that? Do you already have financing providers lined up and you kind of know the parameters of what they're willing to do or do you originate the loan first and then go find those note-on-note providers later? And then what type of spread are you getting on your return versus the note-on-note provider? And maybe where are they attaching?
Yes. Let me -- Stephen, it's Matt again. Let me start and then Patrick just whatever I missed, you should jump in and answer as well. First of all, I think we know who the providers are. We've been -- we've always had a good dedicated team within our capital markets business that is continuously developing those relationships. We obviously have existing lenders within KREF. We have existing lenders within private funds that we manage. So we've got a pretty good pulse on the market and we've got a global platform. So it is very much a global effort in terms of developing those types of facilities. So that's first.
Second comment, we are seeing new entrants pop into that market and we're seeing existing participants expand their programs. So the path of -- the direction of travel here is pretty identifiable in terms of what the banks are trying to accomplish. And so we should be able to really draft off of that and benefit from that.
From a leverage perspective, it's not too dissimilar from where we were previously, call it, 75% to 80% advance rate with the banks solving for somewhere in a look-through LTV in the 50% range, low-50% range, typically speaking. Obviously, it's a little bit deal dependent or property type dependent. And I'd say that financing is currently priced in the SOFR plus 150 to 175 area for the most part for the types of opportunities that we're focused on, which as you recall, like tend to be more institutional, more light transitional. Certainly, that price could widen as you get into longer-dated or heavier business plans.
And I think the most notable -- outside of just the shift in terms of how the banks are thinking about their capital treatment and the magnitude or the quantum of capital that -- in that market today, I'd say, the biggest shift is just there is much more of a willingness to do non-mark-to-market facilities than there has been in the past. We used to spend a ton of time scouring the globe, looking for relationships where we can develop those non-mark-to-market facilities. I would say, that's almost more regular way, maybe not quite there yet, but almost regular way at this point in time for these facilities. And so we'll continue to push that dialogue, because obviously, that's been an important risk mitigant feature for KREF in particular, but for the industry as a whole.
Patrick, anything you'd add to that?
No, I think that's well covered, Matt.
And our next question comes from Jade Rahmani with KBW.
Just on the watch list and REO, could you give some parameters as to timing? Do you expect the bulk of REO and watch list to be resolved, say, over the next year or how would you frame that?
Jade, it's Matt. Thanks for the question. Hard one to say. Obviously, a lot of the -- some of that -- a lot of that timing is out of our control. Let's break it apart a little bit. On the watch list loans, I would say, those hopefully over the next year or the next few quarters, we should be able to deal with those. Unclear which direction those could go. Those are both multifamily loans at this point in time.
And as you start to think about where we are, and we highlighted this on the call, we're really very focused on the fact that we haven't put more into that 4-rated bucket over the last couple of quarters. So I think that's important that we're not seeing that 3 to 4 transition. And of course, unfortunate, don't love the fact that some went to 4 to 5 and we increased reserves. But in some ways, that's a positive thing in the sense that we're getting -- kind of getting through it and identifying it and moving on. So I'd say, the 4s are probably a little bit more identifiable hopefully next few quarters.
And then on the REO side, let's just talk about each one is probably most helpful. So our Lloyd Center in Portland, that one, we continue to make really good progress in terms of entitlements and hope to submit and receive back kind of city approval, call it, first half of next year, at which point we could begin to have some liquidity events in that particular asset. That's a little bit more identifiable just how far we are down the road and that's a pretty exciting project. And so I think we're continuing to push that particular one forward.
When you think about Mountain View, that one is probably the biggest unknown. It's a campus-like facility. It sets up really well for a single tenant. And this is the one where we're just going to have to be patient and wait for the market to come back a little bit. We are on a very short list of assets that gets attention when a large tenant comes into the market and is looking for that unique campus setting. And so we'll continue to try to position ourselves well for that tenant demand. But just given the nature of catching a single tenant, it's really hard to predict when we could resolve that, but certainly, it can take all of next year.
When we think about the Seattle Life Science deal, a little different story because that's multi-tenant. And so we're pushing that business plan forward thinking about putting an incubator space. We're actively engaged in the market right now with a potential tenant for a floor or 2 of that. And so that one is I'm hoping that over the next few quarters, while we may not fully resolve it, we can at least provide updates as we begin the leasing on that on more of a granular basis.
And then that leaves the last one, which is the Philadelphia asset. It's 2 -- if you recall, 2 assets. We have an office and a garage left. We'll likely try to sell the garage probably by the end of the year here. And then the office we'll likely keep on a longer term hold, but this one has moved around a little bit from an execution perspective over the last couple of quarters. So we'll keep you posted. But that's an update as I work through the list of what we have in REO. And hopefully, it's obviously a meaningful component of the portfolio now, not only from just an equity investment perspective, but as we repatriate that capital gives us the ability to obviously generate more earnings. So we'll try to keep everybody updated as we get into 2025.
Any assets where you could see upside? It sounds like your commentary was a little more positive around Portland and also maybe the garage, Philadelphia garage.
Well, yes. I mean, I think that the...
Upside to your basis.
No, understood. Well, I guess, the best way to think about it is when we talk about the potential to drive earnings with that repatriated capital, that analysis or that math is based on our current cost, our current hold. It's not based on any potential increase from there. And I think on some of these, we will do better than that. Obviously, as you go from an unleased asset to a leased asset, depends on the parameters and where you leased it and other factors. But I'm hoping that we can do better than kind of where we hold it today on a number of these, but that remains to be seen as we try to execute those business plans.
The Raleigh and San Diego multifamily, it sounds like you expect resolution and will be somewhat in line with your basis, KREF's basis?
I think I don't -- we don't know yet, right? They're 4-rated loans. They're on the watch list. They're both performing. Our experience I think has been, as loans hit the 4, I think roughly half have gone back to performing and half have ended up in a work-out scenario as a 5-rated loan. So I don't think we want to make any predictions right there if we knew that we would likely either have them as a 3 than 5. But -- so there's still some uncertainty in those.
I think they're multifamily deals. So losses in that segment seem to be relatively contained. And we'll stick with our comments that we've made over the last few quarters that multi is a big part of our portfolio. We've seen a lot of liquidity in that sector, probably more than we would have initially expected, if you told me rates were going to go up 500 basis points. But we're not -- obviously not totally immune from potential losses there, but we think it's going to be relatively contained and certainly more noise than real impact on book value over time.
And West Hollywood catches the attention because it's such a high dollar amount per unit. Is the plan to convert it to condos?
Right now, it's operating as a multifamily. You're right to point out that it's a pretty high -- it's a high basis per unit or per foot. It was originally built as condo and then operated as multi. My guess is that the best path forward will likely be a condo sell-out on that one.
Okay. And it can be quite easily entitled for that?
Yes.
Okay. And then just lastly, the San Carlos Life Science. So in your commentary, you flagged Mountain View, California as sort of the biggest risk. I would assume San Carlos might be second. And in the modification that you're discussing, is the goal to have a longer term modification considering the size of this project?
Yes. This one I think we need to be a little bit careful on just because we're right in the middle of negotiations. But our first preference is always to work with our existing sponsors. And so if we can get to a deal with them, then hopefully, we can create the basis that makes sense for everybody and give the asset more time to implement its business plan. And so that's really path 1 for us, but let's see what happens. I think we've increased our reserves to try to reflect some of the current dialogue that's going on there. And hopefully, we can get to a deal.
Our next question comes from Don Fandetti with Wells Fargo.
Can you talk about your updated thoughts on the office market? Are you seeing increased debt and equity interest? And then also, what is the buyer profile of the loan that you sold in Q4, your office loan?
Yes. Thank you, Don, for the question. It's Matt again. I think the office market is beginning -- it's beginning to show a little bit more liquidity on the capital market side. If you looked last year, for instance, most of the buyers there were high net worth large family offices, really no institutional investors in the market for acquisitions. And now I think you're beginning to see signs of institutional investors coming back into the market. And like all these -- like as you'd expect in these type of large downturns, liquidity is coming back for the best assets first. So for the highest quality assets, the newest assets, the assets that have some long walls associated with them, for instance. And so we'll see if that continues.
On the financing side, I think the same is true. There's not a lot of velocity in people's loan -- office loan portfolios right now. So there's still a really, really high bar to make a new office loan since you're not getting repaid on any. But you're starting to see lending return, especially in sub-markets that have shown real strength over the course of the last couple of years or assets with very long lease terms, as you'd expect. So it's beginning. The capital markets are starting to come back for office. CMBS and SASB have done a number of deals, notably Rock Center, which is obviously a multi-billion dollar transaction or offering in the market. So you think you're beginning to see signs of life on the capital markets front overall. In terms of the loan that we sold, it went to effectively an office equity investor.
Our next question comes from Tom Catherwood with BTIG.
Matt, maybe following up on Rick's question from the start. With the increase in transaction activity that you mentioned, are you seeing that for opportunistic and value-add type deals that would kind of traditionally be looking for transitional type loans or the transactions more core and core plus type assets at the moment?
Yes, I can take that. I would say, the market is -- it's always more weighted towards core, core plus type of lending opportunities. So that's always a larger component of the overall market. I do think that over the course of the last 18 months, that transitional type of capital, let's just call it, a little bit higher cost of capital has been more difficult to lend. So when I think about like a KREF shareholder over the last, call it, 12 to 18 months from like just a new opportunity perspective, there hasn't been -- it hasn't been like the best I think lending environment. Certainly, values have been down, competition has been down. But the demand for transitional loans hasn't been particularly high, to your point.
What we're seeing now is that demand increase for sure. I think it largely is due to 2 things. #1, there's just been like a reboot in acquisition activity and I think this type of capital is more relevant to that segment of the market. And then secondly, we've seen a lot of activity in just capital structures are maturing and borrowers don't want to sell or owners don't want to sell. So they need more time. Their existing lenders kind of run out of time. And so a number of the opportunities we're seeing are just a bridge, right?
Just purely -- not necessarily the business plan is transitional, it's just the market -- the owner wants more time for the market to continue to heal and cost of capital to continue to come down and then they could sell into a better market. So I'd say, that part is picking up and we've seen a lot of that in our own pipeline. And our expectation is as we go into next year, that will be -- there will be a pretty robust opportunity set as the market -- overall market reboots.
I appreciate those thoughts, Matt. And kind of along the same lines, last question for me. But does -- if transaction activity is beginning to ramp, especially for assets that need transitional loans, plus you're sitting on kind of material liquidity, do you need to wait to get to 2025 repayment activity to start ramping new originations or is this something where you could start in the fourth quarter or the first quarter start putting capital to work and levering up a bit and then bring that back down as you get more repayments or does this really have to be match funded as you get those repayments in '25?
That's a good question. I don't -- we have enough liquidity. I don't think we need to like completely match these things up. I think we could probably get ahead of it a little bit. We're actively in the market today looking at transactions a little bit. We do have a big election coming up here in the next few weeks. Honestly, I'm not like personally that motivated like put it out in the next 2 weeks. Let's see what happens with the election, any volatility around that. But certainly, from just a KREF perspective, we have the liquidity today that we could try to get ahead of it a little bit.
[Operator Instructions] And our next question today will come from Steve Delaney with Citizens JMP Securities.
Look, your comments, it's clear that you're in a process of shifting from defense to offense. As we look at the loan portfolio, I'm looking at your Page 20 of your deck, excluding the REO, you're about $6.8 billion in commitments currently. As you look out to 2025, I mean, could that number reach as much as, say, $8 billion? Do you have a figure in mind that's sort of your fully invested portfolio, loan portfolio, what would that look like from a size standpoint?
Steve, it's Patrick. I'll take that question. I think the way you should think about it is if you think about our current portfolio today and our future funding obligations, that's probably the steady state for the equity we have today. And so I think what you should be hearing from us is that as we're getting repayments, we're going to replace those assets with new originations. And so I'm not expecting a lot of change off of that number. We're kind of in our target leverage zone. So I would think about that as kind of being, absent new capital coming in, sort of a portfolio size towards the end of 2025.
Okay. Got it. And as far as your CLOs go, as part of this renewing the activity with lending, do you have some efficiency that you could achieve in CLO financing? I don't -- I believe you're out of your reinvestment period in all of those so they would be -- they're in run-off mode, I assume. Is that accurate that they are? And are you thinking about a new CLO as part of your kind of refreshed lending strategy?
Yes, that's a great question, Steve. So both of our CLOs just exited their replenishment periods this year. And so they were fully invested at the end of those replenishment periods. At this point, obviously, any repayments delever us and slightly increase our cost of capital as we pay back the cheapest liabilities. But given where we sit today, it takes quite a bit of repayments to actually get us to a level that's probably unattractive from a financing standpoint.
That said, if you look at the CLO market over the last couple of months, we've seen a lot of improvement there. We've seen improvement in terms of appetite from investors. And that's driving the cost of capital down on these new CLOs. So I expect that market to continue to provide some tailwinds overall. Sometimes the assets lead, sometimes the liabilities lead, but we're seeing tightening on the liabilities, both in terms of what Matt had referenced from the bank financing, but now also in the capital markets on the CLO side. So as we think about over time those CLOs becoming less efficient for us, the market is setting up well for us to be able to refinance what's left of those CLOs at some point and then to add new collateral that we're starting to originate going into 2025.
And our next question today is a follow-up from Jade Rahmani of KBW.
Just wanted to ask if you're seeing any uptick in loan portfolio sales from banks or credit risk transfers, situations like that where perhaps KREF might participate?
Jade, it's Matt again. On the loan portfolio sales side, it's been pretty muted still. We have not seen a lot come through that channel. And what's come through feels more sub-performing, non-performing loan. And honestly, it's less big pools than it is one-off 1 or 2 loans at a time. So it's not an area, honestly, we've been really engaged with. I haven't seen anything particularly interesting there.
On the credit risk transfer side, that we've seen a little bit of pick-up in that market. I think banks are trying to figure out how do you adapt where they've had success in more granular loan portfolios on the consumer or on the resi side to commercial, where as we know, credits are more idiosyncratic, control is more important. And it's not as much kind of statistical analysis around performance and losses. So it's been interesting to watch as that begin, I would say, very beginning stages, but begins to develop. And it's something we'll certainly stick close to. And it's I think another way for the banks to kind of come at almost like a loan-on-loan facility from an existing portfolio perspective. So nothing large in that market yet, but certainly, conversations have begun.
This concludes our question and answer session. I would like to turn the conference back over to Jack Switala for any closing remarks.
Great. Thanks, operator, and thanks everyone for joining today. Please reach out to me or the team here if you have any questions. Take care.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.